Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):917-24. doi: 10.1167/iovs.05-0854.

Abstract

Purpose: To quantify retinal nerve fiber layer thickness (RNFLT) and macular thickness (MT) in patients exhibiting vigabatrin-attributed visual field loss (VAVFL) and to determine the efficacy of these measures as markers of the retinal damage associated with vigabatrin.

Methods: This was a prospective cross-sectional observational study involving five groups: Group I, 13 patients exhibiting VAVFL; Group II, 8 patients exposed to vigabatrin but with normal fields; Group III, 14 patients receiving carbamazepine monotherapy; Group IV, 20 normal individuals; and Group V, 7 patients receiving sodium valproate monotherapy. At one of two visits, the right eye of each participant underwent two digital imaging modalities: ocular coherence tomography (OCT; StratusOCT; Carl Zeiss Meditec, Dublin, CA) and scanning laser ophthalmoscopy (SLO; Heidelberg Retinal Tomograph; Heidelberg Engineering GmbH, Heidelberg, Germany). At the other visit, participants underwent three-zone, age-corrected suprathreshold perimetry of the whole field and threshold perimetry of the central field (Humphrey Field Analyzer 750; Carl Zeiss Meditec). The order of the visits was randomized.

Results: The group mean RNFLT in Group I was attenuated relative to that of the remaining groups (all P < 0.001). At 100% specificity, based on the 95% confidence limits derived from Group IV, OCT exhibited 100% sensitivity and SLO 77% sensitivity for an attenuated RNFLT in patients with VAVFL. All participants manifested an MT within the normal range derived from Group IV.

Conclusions: OCT of the RNFL can efficiently identify vigabatrin-induced damage and will be useful for adults and children unable to perform perimetry and when the perimetric outcome is equivocal.

MeSH terms

  • Adult
  • Anticonvulsants / adverse effects*
  • Carbamazepine / therapeutic use
  • Cross-Sectional Studies
  • Epilepsy / drug therapy
  • Female
  • Humans
  • Male
  • Nerve Fibers / drug effects
  • Nerve Fibers / pathology*
  • Ophthalmoscopy
  • Prospective Studies
  • Retinal Ganglion Cells / drug effects
  • Retinal Ganglion Cells / pathology*
  • Sensitivity and Specificity
  • Tomography, Optical Coherence
  • Valproic Acid / therapeutic use
  • Vigabatrin / adverse effects*
  • Vision Disorders / chemically induced
  • Vision Disorders / diagnosis*
  • Visual Field Tests
  • Visual Fields / drug effects*

Substances

  • Anticonvulsants
  • Carbamazepine
  • Valproic Acid
  • Vigabatrin